Indiana University School of Medicine, Division of Gastroenterology/Hepatology, Indianapolis, USA.
Endoscopy. 2017 Nov;49(11):1069-1074. doi: 10.1055/s-0043-113445. Epub 2017 Jul 28.
Current recommendations are to calculate the adenoma detection rate (ADR) in screening colonoscopies only. The need to confine the measure to screening has not been established. We retrospectively assessed our quality database for whether calculating ADR from screening, surveillance, and diagnostic colonoscopies (overall ADR) would alter conclusions about the performance of colonoscopists, compared to using an ADR based only on screening colonoscopies. We also prospectively tested the extent to which one physician could corrupt the screening-only ADR by changing the procedure indication after reviewing the examination findings. For 15 physicians, screening ADRs differed from the overall ADR by a mean of 2.6 percentage points (range 0 - 6.9 percentage points). Using the overall ADR rather than screening ADR changed the ADR from just below to just above the recommended screening threshold for one physician. In the prospective assessment, a single expert colonoscopist utilized indication gaming in patients with both screening and diagnostic indications and was able to increase his apparent screening-only ADR from 48.4 % to 55.1 %. Use of an overall ADR rather than screening-only ADR could simplify ADR measurement, increase the number of examinations available to measure ADR, seldom affect whether a doctor meets recommended ADR thresholds, and eliminate the potential for gaming the ADR by changing the colonoscopy indication.
目前的建议是仅在筛查结肠镜检查中计算腺瘤检出率(ADR)。尚未确定将该措施仅限于筛查的必要性。我们回顾性地评估了我们的质量数据库,以确定从筛查、监测和诊断结肠镜检查中计算 ADR(总 ADR)是否会改变对结肠镜检查医生表现的结论,与仅使用基于筛查结肠镜检查的 ADR 相比。我们还前瞻性地测试了一位医生在审查检查结果后更改手术指征会在多大程度上篡改仅筛查 ADR。对于 15 位医生,筛查 ADR 与总 ADR 的差异平均为 2.6 个百分点(范围为 0 至 6.9 个百分点)。使用总 ADR 而不是筛查 ADR,会使一位医生的 ADR 从略低于推荐的筛查阈值变为略高于该阈值。在前瞻性评估中,一位经验丰富的结肠镜专家在具有筛查和诊断指征的患者中使用指征游戏,并能够将其表面上的仅筛查 ADR 从 48.4%提高到 55.1%。使用总 ADR 而不是仅筛查 ADR 可以简化 ADR 测量,增加可用于测量 ADR 的检查数量,很少会影响医生是否达到推荐的 ADR 阈值,并消除通过更改结肠镜检查指征来操纵 ADR 的可能性。